GENELUX Corp Files 2024 Annual Report Amendment
Ticker: GNLX · Form: 10-K/A · Filed: Apr 29, 2025 · CIK: 1231457
| Field | Detail |
|---|---|
| Company | Genelux Corp (GNLX) |
| Form Type | 10-K/A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
GENELUX filed its 2024 10-K amendment, check for updates on financials and biz ops.
AI Summary
GENELUX Corporation filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, dated April 29, 2025, provides updated information regarding the company's operations and financial status. GENELUX Corporation is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This amendment provides updated disclosures for investors and stakeholders regarding GENELUX Corporation's financial performance and business operations for the fiscal year 2024.
Risk Assessment
Risk Level: low — This filing is an amendment to a standard annual report and does not appear to contain significant new negative information.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the annual report.)
- 2025-04-29 — Filing Date (The date the amendment was submitted to the SEC.)
Key Players & Entities
- GENELUX Corporation (company) — Filer of the 10-K/A amendment
- 2024-12-31 (date) — Fiscal year end for the report
- 2025-04-29 (date) — Filing date of the amendment
- Delaware (jurisdiction) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific information is being amended in this 10-K/A filing?
The filing is an amendment (No. 1) to the annual report for the fiscal year ended December 31, 2024, indicating updates or corrections to the original filing.
What is GENELUX Corporation's primary business sector?
GENELUX Corporation is classified under Standard Industrial Classification 2834, which corresponds to Pharmaceutical Preparations.
In which state is GENELUX Corporation incorporated?
GENELUX Corporation is incorporated in Delaware.
What is the SEC file number for GENELUX Corporation?
The SEC file number for GENELUX Corporation is 001-41599.
What is the principal executive office address for GENELUX Corporation?
The principal executive offices are located at 2625 Townsgate Road, Suite 230, Westlake Village, California, 91361.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding GENELUX Corp (GNLX).